New Zealand markets closed

Hua Medicine (Shanghai) Ltd. (2552.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.550-0.040 (-2.52%)
As of 01:18PM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 1.56B
Enterprise value 169.31M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)18.87
Price/book (mrq)14.34
Enterprise value/revenue 2.06
Enterprise value/EBITDA -11.55

Trading information

Stock price history

Beta (5Y monthly) 1.59
52-week change 3-4.22%
S&P500 52-week change 324.43%
52-week high 32.780
52-week low 31.290
50-day moving average 31.561
200-day moving average 31.705

Share statistics

Avg vol (3-month) 31.12M
Avg vol (10-day) 31.26M
Shares outstanding 5980.52M
Implied shares outstanding 6984.84M
Float 8630.42M
% held by insiders 113.64%
% held by institutions 134.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -275.73%
Operating margin (ttm)-3,251.74%

Management effectiveness

Return on assets (ttm)-14.84%
Return on equity (ttm)-110.96%

Income statement

Revenue (ttm)76.61M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)-64.30%
Gross profit (ttm)N/A
EBITDA -322.24M
Net income avi to common (ttm)-211.23M
Diluted EPS (ttm)-0.240
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.46B
Total cash per share (mrq)1.49
Total debt (mrq)167.75M
Total debt/equity (mrq)165.85%
Current ratio (mrq)6.24
Book value per share (mrq)0.10

Cash flow statement

Operating cash flow (ttm)889.37M
Levered free cash flow (ttm)249.64M